PharmiWeb.com - Global Pharma News & Resources
19-Jul-2019

Orthopedic Biomaterials Market Will Grow 10.0% to a Record $ 26 Billion by 2026

The Global Orthopedic Biomaterials Market Size is anticipated to around USD 26 billion by 2026, this market is anticipated to grow with 10.0% CAGR during the forecast time period 2019 to 2026. Acumen Research and Consulting, Recently Published Report titled ldquo;Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics amp; Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026rdquo;.

A major factor driving the market is the increased prevalence of degenerative joint diseases and musculoskeletal disorders. Moreover, the growing geriatric population, which is prone to orthopedic circumstances owing to low bone density and the development of illnesses associated with bone, is anticipated to increase the product supply over the forecast era.

Due to the increasing demands for these products owing to its elevated pressure intensity, ceramics amp; bioactive glass were the dominant product type category in 2018. Furthermore, ceramic amp; bioactive glass biomaterials have an excellent affinity to integrate with the surface material of the bone than their counterparts. Due to the high use of these materials for the reconstruction and fixation of the spine, hip and knee, the polymer biomaterial segment is expected to be the fastest CAGR between 2019 and 2026.

The implementation segment was resulted by orthopedic implants in 2018 and is anticipated to continue in dominance over the forecast period. One of the main variables driving development in this section is an increasing amount of instances of trauma. From 2019 to 2026, the fastest CAGR in the sector of orthobiology is expected to be 10.5%. Increasing use of biomaterial for spinal and other reconstructive surgeries in different orthobiological applications is expected to lead to development in this section.

Download Free Sample Report Pages for Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/1530

A increasing market in America is the North American market in orthopedic biomaterials. The region of America is divided into North America and South America on a regional basis. The US and Canada are divided into North America. The growing incidence of various orthopedic procedures, along with the growing elderly population, is likely to speed up the market. In addition, increased awareness of biodegradable products, increased healthcare and rising demand for sophisticated medicines and products, together with increased public assistance, is probable to increase the development of North America's orthopedic biomaterials industry. For example, in 2016, around 1.61.040 joint substitution procedures took place in the United States, according to the American Joint Replacement Registry.

The fastest-growing market is anticipated in Asia Pacific. The increase in chronic diseases is the main driving force behind the development of the industry. As the population increases, China is the fastest growing area due to an increasing number of patients. The market in this region is driven by increasing awareness of the safety and access to fresh therapy techniques. The development of the biomaterial orthopedics industry in Asia-Pacific is driven by higher healthcare expenses and increased living standards.

Middles of consciousness, restricted access, and the accessibility of therapy services are anticipated to demonstrate the slower development in the market for the Middle East and Africa. Due to the increased health care spending and the general development in the healthcare situation, the United Arab Emirates is the biggest market in the Middle East.

Key Highlights

Due to a big patient pool and elevated awareness of the use of biologically absorbable biomaterials, North America accounted for the biggest income share in 2018.

Due to the enhanced use of this biomaterial for the reconstruction of the damaged tissue and fixation surgeries and joint replacement surgery, ceramics and the bioactive glass segment resulted the market in 2018.

Due to an increase in the world's trauma instances, orthopedic implants were the most important application category in 2018.

Key Players amp; Strategies

With a few smaller respondents, the worldwide sector is oligopolistic in nature. Some vital companies operating in this market include DePuy Synthes Inc.; DSM Biomedical; Stryker Corp.; Invibio Ltd.; AdvanSource Biomaterials Corp.; Zimmer Biomet; Globus Medical; Matexcel; Exactech, Inc.; CAM Bioceramics B.V.; Evonik Industries AG; and Heraeus Holding.

View Detail Information at https://www.acumenresearchandconsulting.com/orthopedic-biomaterials-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Orthopedic Biomaterials
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Orthopedic Biomaterials Market By Material Type
1.2.2.1. Global Orthopedic Biomaterials Market Revenue and Growth Rate Comparison By Material Type (2015-2026)
1.2.2.2. Global Orthopedic Biomaterials Market Revenue Share By Material Type in 2017
1.2.2.3. Calcium Phosphate Cements
1.2.2.4. Ceramics amp; Bioactive Glasses
1.2.2.5. Polymers
1.2.2.6. Composites
1.2.2.7. Metal
1.2.3. Orthopedic Biomaterials Market By Application
1.2.3.1. Global Orthopedic Biomaterials Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Global Orthopedic Biomaterials Market Revenue Share By Application in 2017
1.2.3.3. Joint Replacement/Reconstruction
1.2.3.4. Orthopedic Implants
1.2.3.5. Viscosupplementation
1.2.3.6. Bio-resorbable Tissue Fixation
1.2.3.7. Orthobiologics
1.2.4. Orthopedic Biomaterials Market by Geography
1.2.4.1. Global Orthopedic Biomaterials Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Orthopedic Biomaterials Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Orthopedic Biomaterials Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Orthopedic Biomaterials Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Orthopedic Biomaterials Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Orthopedic Biomaterials Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Orthopedic Biomaterials Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Orthopedic Biomaterials Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Orthopedic Biomaterials Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Orthopedic Biomaterials Major Manufacturers in 2017

CHAPTER 4. ORTHOPEDIC BIOMATERIALS MARKET BY MATERIAL TYPE

4.1. Global Orthopedic Biomaterials Revenue By Material Type
4.2. Calcium Phosphate Cements
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Ceramics amp; Bioactive Glasses
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Polymers
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Composites
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Metal
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ORTHOPEDIC BIOMATERIALS MARKET BY APPLICATION

5.1. Global Orthopedic Biomaterials Revenue By Application
5.2. Joint Replacement/Reconstruction
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Orthopedic Implants
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Viscosupplementation
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Bio-resorbable Tissue Fixation
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Orthobiologics
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ORTHOPEDIC BIOMATERIALS MARKET BY COUNTRY

6.1. North America Orthopedic Biomaterials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Orthopedic Biomaterials Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Orthopedic Biomaterials Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ORTHOPEDIC BIOMATERIALS MARKET BY COUNTRY

7.1. Europe Orthopedic Biomaterials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Orthopedic Biomaterials Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET BY COUNTRY

8.1. Asia-Pacific Orthopedic Biomaterials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Orthopedic Biomaterials Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ORTHOPEDIC BIOMATERIALS MARKET BY COUNTRY

9.1. Latin America Orthopedic Biomaterials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Orthopedic Biomaterials Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST ORTHOPEDIC BIOMATERIALS MARKET BY COUNTRY

10.1. Middle East Orthopedic Biomaterials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Orthopedic Biomaterials Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA ORTHOPEDIC BIOMATERIALS MARKET BY COUNTRY

11.1. Africa Orthopedic Biomaterials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Orthopedic Biomaterials Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Material Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. DePuy Synthes Inc.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. DSM Biomedical
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Stryker Corp.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Invibio Ltd.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. AdvanSource Biomaterials Corp.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Zimmer Biomet
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Globus Medical
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Matexcel
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Exactech, Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. CAM Bioceramics B.V.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Evonik Industries AG
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Heraeus Holding
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. Others
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Request for Customization: https://www.acumenresearchandconsulting.com/request-customization/1530

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1530

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 19-Jul-2019